Sinovac Gets Funding for Flu Vaccine
9th Dec 2005, 23:44 GMT
Beijing-based vaccine developer Sinovac Biotech said it received 7 mln yuan from China's Ministry of Science and Technology for preclinical trials of its proprietary pandemic flu vaccine, Panflu.
Sinovac Gets Funding for Flu Vaccine related news:
- Sinovac Receives Gov't Funding for Pandemic Flu Vaccine R&D — Bio-Technology News from StratCenter.com
- A bottle containing a vaccine against bird flu from Sinovac ... — Bird Flu on Yahoo! News Photos
- Sinovac Receives Government Funding for Pandemic Flu Vaccine Research and Development — PR Newswire: All Releases
- A vaccine against bird flu from Beijing-based pharmaceutical ... — Bird Flu on Yahoo! News Photos
- Nasal flu vaccine beats flu shots in trial — MSNBC.com: Health
- MedImmune nasal flu vaccine beats flu shots in trial (Reuters) — Yahoo! News: Health News
- Wide-spread Use Of Intranasal Flu Vaccine Does Not Show Unexpected Serious Risks — ScienceDaily Headlines: Health & Medicine
- Study Shows Inhaled Flu Vaccine Safe (Associated Press) —
- Study: Inhaled Flu Vaccine Safe — cbs2chicago.com: Chicago news, weather, traffic, video from WBBM-TV: Health
- Will bird flu vaccine work? — CNN.com - Health
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress